← All stocks

Tarsus Pharmaceuticals, Inc.

TARS Net selling
CIK 0001819790 #1728 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$19.31M
$12.03M on a plan · $0.00 straight out of an exercise
Sold at will
$7.28M
23 of 57 sales
Net
−$19.31M
−$7.28M against sales at will

By person

14 insiders · 57 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Azamian Bobak R.
President/CEO and Board Chair
$5.51M (11) scheduled
−$5.51M
1,709,403
3.90%
$145.30M
−2.7%
LINK WILLIAM J PHD
Director
$3.50M (10) scheduled
−$3.50M
106,786
0.2433%
$9.08M
−39.9%
Whitfield Dianne C.
Chief Human Resources Officer
$2.69M (8) scheduled
−$2.69M
35,028
0.0798%
$2.98M
+2.5%
Lin Elizabeth Yeu
Chief Medical Officer
$2.36M (11) scheduled
−$2.36M
16,177
0.0369%
$1.38M
−51.4%
Neervannan Seshadri
Chief Operating Officer
$2.00M (6) scheduled
−$2.00M
79,482
0.1811%
$6.76M
+18.2%
Farrow Jeffrey S
See Remarks
$1.32M (4)
−$1.32M
56,801
0.1294%
$4.83M
+213.2%
Mottiwala Aziz
Chief Commercial Officer
$892.53K (3)
−$892.53K
61,480
0.1401%
$5.23M
+11.5%
Wahl Bryan
General Counsel
$850.42K (3)
−$850.42K
63,959
0.1457%
$5.44M
+50.0%
Goodrich Katherine
Director
$183.38K (1) scheduled
−$183.38K
2,233
0.0051%
$189.81K
Goldberg Andrew D.
Director
19,654
0.0448%
$1.67M
+209.5%
YARNO WENDY L
Director
16,654
0.0380%
$1.42M
+60.9%
CHAUDHURI BHASKAR
Director
11,654
0.0266%
$990.59K
+117.8%
Morrison Scott W
Director
7,638
0.0174%
$649.23K
+27.0%
PYOTT DAVID E I
Director
1,383
0.0032%
$117.56K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 58
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 34
Sales straight out of an exercise 0
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 292,091
History held since 20 Oct 2020